CliffBio
small molecule

TUXARIN ER

CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

Loss of exclusivityJanuary 2032latest FDA-listed patent expiry
CompanyMAINPOINTE PHARMACEUTICALS, LLC →See this company's full patent-cliff portfolio

Drug detail

Brand nameTUXARIN ER
Active ingredientCHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE
Strength8MG;54.3MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2015
Marketing statusRX

Listed patents

PatentExpiresType
9066942January 2032use U-1716
9107921January 2032product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.